This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Sorbonne Université. Active years: 2021.
Company Filing History:
1 out of 5,383 
1 out of 1,853 
1 out of 263 Years Active: 2021
Title: Bertrand Callippe: Innovator in Inflammatory Disorder Treatments
Introduction
Bertrand Callippe is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory disorders. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Bertrand Callippe holds a patent for "Agents that inhibit the binding of CFH to CD11b/CD18 and uses thereof." This patent discloses agents that inhibit the interaction between CFH and CD11b/CD18. The agents are particularly useful for treating inflammatory disorders, such as age-related macular degeneration. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Bertrand has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and the National Institute of Health and Medical Research. His work in these organizations has allowed him to contribute to groundbreaking research and innovations in the medical field.
Collaborations
Bertrand has collaborated with esteemed colleagues, including Jose-Alain Sahel and Florian Sennlaub. These partnerships have further enriched his research and have led to advancements in understanding and treating inflammatory conditions.
Conclusion
In summary, Bertrand Callippe is a distinguished inventor whose work has the potential to significantly impact the treatment of inflammatory disorders. His innovative patent and collaborations highlight his dedication to improving health outcomes.